The effects of omega-3 fatty acids on matrix metalloproteinase-9 production and cell migration in human immune cells: Implications for multiple sclerosis

Autoimmune Diseases

Volumn 1, Issue 1, 2011, Pages

  Shinto, Lynne ^a   Marracci, Gail ^b   Bumgarner, Lauren ^a   Yadav, Vijayshree ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Affairs Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; FIBRONECTIN; GELATINASE B; ICOSAPENTAENOIC ACID;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKEMIA CELL LINE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERMEABILITY BARRIER; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 84856539330     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.4061/2011/134592     Document Type: Article

References (29)

1. Hafler D. A., Weiner H. L., Immunologic mechanisms and therapy in multiple sclerosis Immunological Reviews 1995 144 75 107
2. Martin R., McFarland H. F., McFarlin D. E., Immunological aspects of demyelinating diseases Annual Review of Immunology 1992 10 153 187
3. Morales Y., Parisi J. E., Lucchinetti C. F., The pathology of multiple sclerosis: evidence for heterogeneity Advances in Neurology 2006 98 27 45
4. Kappos L., Radue E. W., O'Connor P., Polman C., Hohlfeld R., Calabresi P., Selmaj K., Agoropoulou C., Leyk M., Zhang-Auberson L., Burtin P., A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis New England Journal of Medicine 2010 362 5 387 401
5. The IFNB Multiple Sclerosis Study Group, Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology 1993 43 4 I 655 661
6. Jacobs L. D., Cookfair D. L., Rudick R. A., Herndon R. M., Richert J. R., Salazar A. M., Fischer J. S., Goodkin D. E., Granger C. V., Simon J. H., Alam J. J., Bartoszak D. M., Bourdette D. N., Braiman J., Brownscheidle C. M., Coats M. E., Cohan S. L., Dougherty D. S., Kinkel R. P., Mass M. K., Munschauer F. E. III, Priore R. L., Pullicino P. M., Scherokman B. J., Weinstock-Guttman B., Whitham R. H., Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis Annals of Neurology 1996 39 3 285 294 (Pubitemid 26100751)
7. Johnson K. P., Brooks B. R., Cohen J. A., Ford C. C., Goldstein J., Lisak R. P., Myers L. W., Panitch H. S., Rose J. W., Schiffer R. B., Vollmer T., Weiner L. P., Wolinsky J. S., Bird S. J., Kolson D. L., Gonzalez-Scarano F., Brennan D., Mandler R. N., Rosenberg G. A., Copolymer 1 reduces relapse rate and improves disability in relapsing- remitting multiple sclerosis: results of a phase III multicenter, double- blind, placebo-controlled trial Neurology 1995 45 7 1268 1276
8. PRISMS and S. Group, Randomised double-blind placebo-controlled study of interferon -1a in relapsing/remitting multiple sclerosis Lancet 1998 352 9139 1498 1504
9. Niino M., Bodner C., Simard M. L., Alatab S., Gano D., Kim HO. J., Trigueiro M., Racicot D., Guérette C., Antel J. P., Fournier A., Grand'Maison F., Bar-Or A., Natalizumab effects on immune cell responses in multiple sclerosis Annals of Neurology 2006 59 5 748 754 (Pubitemid 43673152)
10. Rudick R. A., Lee J. C., Simon J., Fisher E., Significance of T2 lesions in multiple sclerosis: a 13-year longitudinal study Annals of Neurology 2006 60 2 236 242 (Pubitemid 44182398)
11. Leppert D., Lindberg R. L. P., Kappos L., Leib S. L., Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis Brain Research Reviews 2001 36 2-3 249 257 (Pubitemid 33020755)
12. Lee M. A., Palace J., Stabler G., Ford J., Gearing A., Miller K., Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study Brain 1999 122 2 191 197 (Pubitemid 29067202)
13. Trojano M., Avolio C., Liuzzi G. M., Ruggieri M., Defazio G., Liguori M., Santacroce M. P., Paolicelli D., Giuliani F., Riccio P., Livrea P., Changes of serum sICAM-1 and MMP-9 induced by rIFN -1b treatment in relapsing-remitting MS Neurology 1999 53 7 1402 1408 (Pubitemid 29491928)
14. Waubant E., Goodkin D. E., Gee L., Bacchetti P., Sloan R., Stewart T., Andersson P. B., Stabler G., Miller K., Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis Neurology 1999 53 7 1397 1401 (Pubitemid 29491927)
15. Bar-Or A., Nuttall R. K., Duddy M., Alter A., Kim HO. J., Ifergan I., Pennington C. J., Bourgoin P., Edwards D. R., Yong V. W., Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis Brain 2003 126 12 2738 2749 (Pubitemid 37463092)
16. Dressel A., Mirowska-Guzel D., Gerlach C., Weber F., Migration of T-cell subsets in multiple sclerosis and the effect of interferon- 1a Acta Neurologica Scandinavica 2007 116 3 164 168 (Pubitemid 47262763)
17. Leppert D., Waubant E., Brk M. R., Oksenberg J. R., Hauser S. L., Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis Annals of Neurology 1996 40 6 846 852 (Pubitemid 27044602)
18. Stve O., Dooley N. P., Uhm J. H., Antel J. P., Francis G. S., Williams G., Yong V. W., Interferon -1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9 Annals of Neurology 1996 40 6 853 863 (Pubitemid 27044603)
19. Gallai V., Sarchielli P., Trequattrini A., Franceschini M., Floridi A., Firenze C., Alberti A., Di Benedetto D., Stragliotto E., Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids Journal of Neuroimmunology 1995 56 2 143 153
20. Curtis C. L., Rees S. G., Cramp J., Flannery C. R., Hughes C. E., Little C. B., Williams R., Wilson C., Dent C. M., Harwood J. L., Caterson B., Effects of n-3 fatty acids on cartilage metabolism Proceedings of the Nutrition Society 2002 61 3 381 389 (Pubitemid 34982929)
21. Harris M. A., Hansen R. A., Vidsudhiphan P., Koslo J. L., Thomas J. B., Watkins B. A., Allen K. G. D., Effects of conjugated linoleic acids and docosahexaenoic acid on rat liver and reproductive tissue fatty acids, prostaglandins and matrix metalloproteinase production Prostaglandins Leukotrienes and Essential Fatty Acids 2001 65 1 23 29 (Pubitemid 32783438)
22. McCabe A. J., Wallace J., Gilmore W. S., Strain J. J., McGlynn H., The effect of eicosapentanoic acid on matrix metalloproteinase gene expression Lipids 1999 34 6 S217 S218
23. Liuzzi G. M., Latronico T., Rossano R., Viggiani S., Fasano A., Riccio P., Inhibitory effect of polyunsaturated fatty acids on MMP-9 release from microglial cellsimplications for complementary multiple sclerosis treatment Neurochemical Research 2007 32 12 2184 2193 (Pubitemid 350059862)
24. Shinto L., Marracci G., Baldauf-Wagner S., Strehlow A., Yadav V., Stuber L., Bourdette D., Omega-3 fatty acid supplementation decreases matrix metalloproteinase-9 production in relapsing-remitting multiple sclerosis Prostaglandins Leukotrienes and Essential Fatty Acids 2009 80 2-3 131 136
25. Marracci G. H., Jones R. E., McKeon G. P., Bourdette D. N., Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis Journal of Neuroimmunology 2002 131 1-2 104 114
26. Lichtinghagen R., Seifert T., Kracke A., Marckmann S., Wurster U., Heidenreich F., Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis Journal of Neuroimmunology 1999 99 1 19 26 (Pubitemid 29488565)
27. zenci V., Rinaldi L., Teleshova N., Matusevicius D., Kiviskk P., Kouwenhoven M., Link H., Metalloproteinases and their tissue inhibitors in multiple sclerosis Journal of Autoimmunity 1999 12 4 297 303 (Pubitemid 29261966)
28. Marsen T. A., Pollok M., Oette K., Baldamus C. A., Pharmacokinetics of Omega-3-fatty acids during ingestion of fish oil preparations Prostaglandins Leukotrienes and Essential Fatty Acids 1992 46 3 191 196
29. Bates D., Cartlidge N. E. F., French J. M., Jackson M. J., Nightingale S., Shaw D. A., Smith S., Woo E., Hawkins S. A., Millar J. H. D., Belin J., Conroy D. M., Gill S. K., Sidey M., Smith A. D., Thompson R. H. S., Zilkha K., Gale M., Sinclair H. M., A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis Journal of Neurology Neurosurgery and Psychiatry 1989 52 1 18 22 (Pubitemid 19043864)